Laurus Labs Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,778.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.55 per cent from ₹1,653.47 crore. This corresponds to a year-on-year *(YoY) growth of 25.67 per cent.
Operating Profit
Operating Profit stands at ₹480.21 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.08 per cent from ₹403.26 crore. This corresponds to a year-on-year *(YoY) growth of 68.41 per cent.
PBDT
PBDT stands at ₹445.95 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.07 per cent from ₹390.96 crore. This corresponds to a year-on-year *(YoY) growth of 86.51 per cent.
Profit Before Tax
Profit Before Tax stands at ₹325.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.28 per cent from ₹270.47 crore. This corresponds to a year-on-year *(YoY) growth of 144.59 per cent.
Net Profit
Net Profit stands at ₹251.88 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.51 per cent from ₹194.49 crore. This represents a 171.01 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Laurus Labs Ltd News
Laurus Labs Ltd Earnings
- YOY
- QOQ
Laurus Labs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Laurus Labs Ltd Research Reports
Laurus Labs Ltd Financial Reports
Laurus Labs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Laurus Labs | 1.36% | -0.52% | 6.59% | 19.65% | 16.06% | 78.57% |
| Aurobindo Pharma | -1.84% | -1.32% | 3.95% | 19.36% | 22.53% | 15.10% |
| Glenmark Pharma. | 0.23% | 4.90% | 14.77% | 24.30% | 27.52% | 75.23% |
| Alkem Lab | -1.34% | 2.13% | 1.90% | -3.95% | -3.03% | 5.27% |
| Biocon | -0.14% | 3.82% | -0.59% | -1.51% | -2.42% | 13.92% |
| Abbott India | 1.27% | 1.51% | -3.44% | -6.32% | -11.80% | -16.82% |
| Anthem Bioscienc | 0.26% | 4.90% | 16.29% | 32.23% | 9.19% | 6.21% |
Company Info
Company Information
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru